The International Center for Cell Therapy & Cancer Immunotherapy (CTCI) provides groundbreaking treatments for patients with cancer or non-malignant diseases. Some of the treatments are provided in Israel, and others are provided in other locations, in accordance with local regulations.

The cancer treatments include a broad range of personalized immune therapies, oncolytic virus therapies, and tailored drug regimens with reduced toxicity.

The treatments for non-malignant diseases include regenerative therapies developed by CTCI for neurological diseases and other conditions correctible by bone marrow or adipose-tissue-derived stem cells.

CTCI’s personalized approaches aim to rehabilitate and/or regulate the patient’s immune system, or to introduce donor immune-system cells, to effectively fight disease.

CTCI’s patients benefit from successful state-of-the-art scientific research that is converted quickly into new treatment protocols.